President and Chief Executive Officer · GILEAD SCIENCES, INC. (GILD)

John Milligan

A named executive officer of GILEAD SCIENCES in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$25,961,831

Salary $1,581,623Stock awards $9,865,666

FY2017: $15,438,459

1st of 5 named executive officers at Gilead Sciences by FY2018 total.

5 named officers on file for GILEAD SCIENCES, FY2018

John Milligan’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • GILD’s disclosed peer group of 10 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how GILEAD SCIENCES’s whole pay program stands against its peers

  • GILEAD SCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GILD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 25, 2019 (DEF 14A).

Free

Get John Milligan’s full pay file as a PDF — free

More than this page: up to 10 years of John’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

John Milligan compensation by year

GILEAD SCIENCES Summary Compensation Table · all 3 fiscal years held
In US dollars, as GILEAD SCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$1,465,385$1,539,462$1,581,623
Bonus$0$0$0
Stock awards$4,349,750$4,894,499$9,865,666
Option awards$5,500,077$5,749,998$11,131,386
Non-equity incentive$2,610,000$3,244,500$3,341,100
Pension and deferred compensation$0$0$0
All other$10,000$10,000$42,056
Total$13,935,212$15,438,459$25,961,831

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: GILEAD SCIENCES, INC. DEF 14A filed March 25, 2019, accession 0001206774-19-001013, and prior-year filings. Open the filing on EDGAR.

How this page was built: the GILEAD SCIENCES, INC. filed document, accession 0001206774-19-001013. Every figure is read from that document and cited to the page and table it appears in. Filed March 25, 2019.

$13.9M
$15.4M
$26.0M
FY16
FY17
FY18
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU26,528$1,659,326—
RSU21,814$1,364,466—
RSU21,672$1,355,584—
RSU19,162$1,198,583—
RSU17,820$1,114,641—
RSU10,604$663,280—
RSU8,617$538,993—
PSU9$563—
PSU7$438—
Option73,694—$84.05
Option4,394—$104.83
Option295,660—$83.49

Per the Outstanding Equity Awards at Fiscal Year-End table in GILEAD SCIENCES, INC.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 13 award rows shown.

GILEAD SCIENCES’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
John Milligan · this pagePresident and Chief Executive Officer$25,961,831
Laura HamillFormer Executive Vice President Worldwide Commercial Operations$10,337,826
John McHutchisonFormer Chief Scientific Officer, Head of Research and Development$7,274,972
Robin WashingtonFormer Executive Vice President, Chief Financial Officer$6,342,671
Gregg AltonChief Patient Officer$4,906,863

The full GILEAD SCIENCES compensation record

free company brief

This page is one person within GILEAD SCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the GILEAD SCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are GILEAD SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

John Milligan's compensation dossier · One-time report. No refunds.